FluoroPharma Medical Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:FluoroPharma Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11428
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of coronary artery disease. Its positron emission tomography imaging agents include VasoPET, cardioPET, BFPET, and AZPET. FluoroPharma provides agents for detection of amyloid plaque in Alzheimer’s disease, inflamed atherosclerotic plaque in peripheral arteries, and agents for detection of certain types of cancer. The company’s technology consists of molecular positron emission tomography agents for the cardiovascular, oncology and neurology arenas. Its products are used in molecular imaging market, cardiovascular market and additional diagnostic markets. FluoroPharma is headquartered in Montclair, New Jersey, the US.

FluoroPharma Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
FluoroPharma Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
FluoroPharma Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
FluoroPharma Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
FluoroPharma Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
FluoroPharma Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
FluoroPharma Medical Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fluoropharma Medical Enters into Option Licensing Agreement with Ground Fluor Pharma 10
FluoroPharma Medical Enters into Licensing Agreement with Sinotau USA 11
FluoroPharma Medical Enters into Partnership with Koninklijke Philips 12
Equity Offering 13
FluoroPharma Medical Raises USD0.2 Million in Final Tranche of Private Placement Shares 13
FluoroPharma Medical Completes First Tranche Of Private Placement Of Preferred Shares And Warrants For US$0.7 Million 14
FluoroPharma Medical Completes First Tranche Of Private Placement Of Shares For US$2 Million 16
Debt Offering 17
FluoroPharma Medical Raises USD0.15 Million in Private Placement of Notes 17
FluoroPharma Medical to Raise up to USD3 Million in Private Placement of 8% Note and Warrants 18
Acquisition 19
FluoroPharma Medical to Acquire Ground Fluor Pharma 19
FluoroPharma Medical Inc – Key Competitors 20
FluoroPharma Medical Inc – Key Employees 21
FluoroPharma Medical Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
FluoroPharma Medical Inc, Medical Equipment, Key Facts 2
FluoroPharma Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
FluoroPharma Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
FluoroPharma Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
FluoroPharma Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
FluoroPharma Medical Inc, Deals By Market, 2012 to YTD 2018 8
FluoroPharma Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fluoropharma Medical Enters into Option Licensing Agreement with Ground Fluor Pharma 10
FluoroPharma Medical Enters into Licensing Agreement with Sinotau USA 11
FluoroPharma Medical Enters into Partnership with Koninklijke Philips 12
FluoroPharma Medical Raises USD0.2 Million in Final Tranche of Private Placement Shares 13
FluoroPharma Medical Completes First Tranche Of Private Placement Of Preferred Shares And Warrants For US$0.7 Million 14
FluoroPharma Medical Completes First Tranche Of Private Placement Of Shares For US$2 Million 16
FluoroPharma Medical Raises USD0.15 Million in Private Placement of Notes 17
FluoroPharma Medical to Raise up to USD3 Million in Private Placement of 8% Note and Warrants 18
FluoroPharma Medical to Acquire Ground Fluor Pharma 19
FluoroPharma Medical Inc, Key Competitors 20
FluoroPharma Medical Inc, Key Employees 21
FluoroPharma Medical Inc, Subsidiaries 22

List of Figures
FluoroPharma Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
FluoroPharma Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
FluoroPharma Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
FluoroPharma Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
FluoroPharma Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
FluoroPharma Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
FluoroPharma Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
FluoroPharma Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[FluoroPharma Medical Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Caterpillar Inc.:企業の戦略・SWOT・財務情報
    Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report Summary Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務情報
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Oceania Cruises, Inc.
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • 4D Molecular Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) is a gene therapy company that deliver genes to specific cells in the body to eradicate rare and large market diseases. The company discovers and develops targeted and proprietary AAV gene therapy vectors and therapeutic products. It …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tokyo Broadcasting System Holdings, Inc. (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings, Inc. (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Lamperd Less Lethal Inc.:企業の戦略・SWOT・財務情報
    Lamperd Less Lethal Inc. - Strategy, SWOT and Corporate Finance Report Summary Lamperd Less Lethal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Monadelphous Group Ltd (MND):企業の財務・戦略的SWOT分析
    Monadelphous Group Ltd (MND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Haier Group:企業の戦略・SWOT・財務情報
    Haier Group - Strategy, SWOT and Corporate Finance Report Summary Haier Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Arla Foods amba:企業の戦略・SWOT・財務情報
    Arla Foods amba - Strategy, SWOT and Corporate Finance Report Summary Arla Foods amba - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Innovative Solutions and Support, Inc.:企業の戦略・SWOT・財務情報
    Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report Summary Innovative Solutions and Support, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Greenergy International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greenergy International Ltd (GIL) is an energy company that sells petroleum products. The company’s products include petrol, diesel, biodiesel, ultra-low sulphur gasoil, bioethanol, kerosene and ULSG. It offers manufacturing and infrastructure, fuel supply, infrastructure investment, biofuel …
  • The Navigator Company:企業の戦略・SWOT・財務情報
    The Navigator Company - Strategy, SWOT and Corporate Finance Report Summary The Navigator Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HD Supply Inc:企業の戦略的SWOT分析
    HD Supply Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BayWa AG:企業のM&A・事業提携・投資動向
    BayWa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BayWa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆